Abstract
This articles reviews the development of mitochondrial medicine from the premolecular era (1962–1988), when mitochondrial diseases were defined on the basis of clinical examination, muscle biopsy, and biochemical criteria, through the molecular era, when the full complexity of these disorders became evident. In a chronological order, I have followed the introduction of new pathogenic concepts that have shaped a rational genetic classification of these clinically heterogeneous disorders. Thus, mitochondrial DNA (mtDNA)-related diseases can be divided into two main groups: those that impair mitochondrial protein synthesis in toto, and those that affect specific respiratory chain proteins. Mutations in nuclear DNA can affect components of respiratory chain complexes (direct hits) or assembly proteins (indirect hits), but they can also impair mtDNA integrity (multiple mtDNA mutations), replication (mtDNA depletion), or mtDNA translation. Besides these disorders that affect the respiratory chain directly, defects in other mitochondrial functions may also affect oxidative phosphorylation, including problems in mitochondrial protein import, alterations of the inner mitochondrial membrane lipid composition, and defects of mitochondrial dynamics. The enormous and still ongoing progress in our understanding of mitochondrial medicine was made possible by the intense collaboration of an international cadre of “mitochondriacs.” Having published my first paper on a patient with mitochondrial myopathy 37 years ago (DiMauro et al., 1973), I feel qualified to write a history of the mitochondrial diseases, a fascinating, still evolving, and continuously puzzling area of medicine. In each section, I follow a chronological order of the salient discoveries and I show only the portraits of distinguished deceased mitochondriacs and those whose names became eponyms of mitochondrial diseases.
Similar content being viewed by others
References
Alexander C, Votruba M, Pesch UEA, Thiselton DL, Mayer S, Moore A et al (2000) OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 26:211–215
Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissiere A et al (2008) OPA1 mutations induce mitochondrial DNA instability and optic atrophy “plus” phenotypes. Brain 131:338–351
Antonicka H, Mattman A, Carlson CG, Glerum DM, Hoffbuhr KC, Leary SC et al (2003) Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy. Am J Hum Genet 72:101–114
Antonicka H, Sasarman F, Kennaway NG, Shoubridge EA (2006) The molecular basis for tissue specificity of the oxidative phosphorylation deficiencies in patients with mutations in the mitochondrial translation factor EFG1. Hum Mol Genet 15:1835–1846
Area-Gomez E, de Groof AJC, Boldogh I, Bird TD, Gibson GE, Koehler CM et al (2009) Presenilins are enriched in mitochondria-associated membranes. Am J Pathol 175:1810–1818
Auré K, Benoist JF, de Ogier Baulny H, Romero NB, Rigal O, Lombes A (2004) Progression despite replacement of a myopathic form of coenzyme Q10 defect. Neurology 63:727–729
Bardosi A, Creutzfeldt W, DiMauro S, Felgenhauer K, Friede RL, Goebel HH et al (1987) Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol 74:248–258
Barth PG, Scholte HR, Berden JA, Moorsel V, Luyt-Houwen I, Van’t Veer-Korthof ET et al (1983) An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 62:327–355
Bione S, D'Adamo P, Maestrini E, Gedeon AK, Bolhuis PA, Toniolo D (1996) A novel X-linked gene, G4.5, is responsible for Barth syndrome. Nat Genet 12:385–389
Blass JP, Avigan J, Uhlendorf BW (1970) A defect in pyruvate decarboxylase in a child with an intermittent movement disorder. J Clin Invest 49:423–432
Bolender N, Sickmann A, Wagner R, Meisinger C, Pfanner N (2008) Multiple pathways for sorting mitochondrial precursor proteins. EMBO J 9:42–49
Bonilla E, Sciacco M, Tanji K, Sparaco M, Petruzzella V, Moraes CT (1992) New morphological approaches to the study of mitochondrial encephalomyopathies. Brain Pathol 2:113–119
Bossy-Wetzel E, Barsoum MJ, Godzik A, Schwartzenbacher R, Lipton SA (2003) Mitochondrial fission in apoptosis, neurodegeneration and aging. Curr Opin Cell Biol 15:706–716
Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequignot E et al (1995) Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 11:144–149
Bykhovskaya Y, Casas KA, Mengesha E, Inbal A, Fischel-Ghodsian N (2004) Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74:1303–1308
Cao L, Shitara H, Sugimoto M, Hayashi J-I, Abe K, Yonekawa H (2009) New evidence confirms that the mitochondrial bottleneck is generated without reduction of mitochondrial DNA content in early primordial germ cells of mice. PloS Genetics 5(12):e1000756
Carelli V, Barboni P, Sadun AA (2006) Mitochondrial ophthalmology. In: DiMauro S, Hirano M, Schon EA (eds) Mitochondrial medicine. Informa Healthcare, London, pp 105–142
Chan DC (2006) Mitochondria: dynamic organelles in disease, aging, and development. Cell 125:1241–1252
Chan DC (2007) Mitochondrial dynamics in disease. New Engl J Med 356:1707–1709
Chinnery PF, Taylor DJ, Brown DT, Manners D, Styles P, Lodi R (2000) Very low levels of the mtDNA A3243G mutation associated with mitochondrial dysfunction in vivo. Ann Neurol 47:381–384
Chomyn A, Enriquez JA, Micol V, Fernandez-Silva P, Attardi G (2000) The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes. J Biol Chem 275:19198–19209
Cizkova A, Stranecky V, Mayr JA, Tesarova M, Havlikova V, Paul J et al (2009) TMEM70 mutations cause isolated ATP synthase deficiency and eonatal mitochondrial encephalomyopathy. Nat Genet 40:12881290
Coenen MJH, Antonicka H, Ugalde C, Sasarman F, Rossi P, Heister JGAMA et al (2004) Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. New Engl J Med 351:2080–2086
Cree LM, Samuels DC, de Sousa Lopes SC, Rajasimha HK, Wonnapinij P, Mann JR et al (2008) A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes. NatGenet 40:249–254
Darin N, Oldfors A, Moslemi A-R, Holme E, Tulinius M (2001) The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities. Ann Neurol 49:377–383
Davey KM, Parboosingh JS, McLeaod DR, Chan A, Casey R, Ferreira P et al (2006) Mutation of DNAJC19, a human homologue of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-kike condition. J Med Genet 43:385–393
De Meirleir L, Seneca S, Lissens W, De Clercq I, Eyskens F, Gerlo E et al (2004) Respiratory chain complex V deficiency due to a mutation in the assembly gene ATP12. J Med Genet 41:120–124
DeFrancesco L, Scheffler IE, Bissell MJ (1976) A respiration-deficient Chinese hamster cell line with a defect in NADH-coenzyme Q reductase. J Biol Chem 251:4588–4595
Dejardins P, Frost E, Morais R (1985) Ethidium bromide-induced loss of mitochondrial DNA from primary chicken embryo fibroblasts. Mol Cell Biol 5:1163–1169
Delettre C, Lenaers G, Griffoin J-M, Gigarel N, Lorenzo C, Belenguer P et al (2000) Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 26:207–210
DiMauro S, DiMauro-Melis PM (1973) Muscle carnitine palmityltransferase deficiency and myoglobinuria. Science 182:929–931
DiMauro S, Schon EA (2008) Mitochondrial disorders in the nervous system. Annu Rev Neurosci 31:91–123
DiMauro S, Hirano M, Schon EA (eds) (2006) Mitochondrial medicine. Informa Healthcare, Abingdon
DiMauro S, Bonilla E, Zeviani M, Nakagawa M, DeVivo DC (1985) Mitochondrial myopathies. Ann Neurol 17:521–538
DiMauro S, Schotland DL, Bonilla E, Lee CP, Gambetti PL, Rowland LP (1973) Progressive ophthalmoplegia, glycogen storage, and abnormal mitochondria. Arch Neurol 29:170–179
Dimauro S, Bonilla E, Lee CP, Schotland DL, Scarpa A, Conn H et al (1976) Luft's disease. Further biochemical and ultrastructural studies of skeletal muscle in the second case. J Neurol Sci 27:217–232
Diomedi-Camassei F, Di Giandomenico S, Santorelli F, Caridi G, Piemonte F, Montini G et al (2007) COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J Am Soc Nephrol 18:2773–2780
Dubeau F, De Stefano N, Zifkin BG, Arnold DL, Shoubridge EA (2000) Oxidative phosphorylation defect in the brains of carriers of the tRNAleu (UUR) A3243G mutation in a MELAS pedigree. Ann Neurol 47:179–185
Duncan AJ, Bitner-Glindziez M, Meunier B, Costello H, Hargreaves IP, Lopez LC et al (2009) A nonsense mutation in COQ9 causes autosomal recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease. Am J Hum Genet 84:558–566
Edvarson S, Shaag A, Kolesnikova O, Gomori JM, Tarassov I, Einbinder T et al (2007) Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am J Hum Genet 81:857–862
Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF (2008) Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 83:254–260
Engel AG, Angelini C (1973) Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome. Science 179:899–902
Engel WK, Cunningham CG (1963) Rapid examination of muscle tissue: an improved trichrome stain method for fresh-frozen biopsy sections. Neurology 13:919–923
Fenton WA (1995) Mitochondrial protein transport-a system in search of mutations. Am J Hum Genet 57:235–238
Fichera M, Lo Giudice M, Falco M, Sturnio M, Amata A, Calabrese O et al (2004) Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia. Neurology 63:1108–1110
Filosto M, Mancuso M, Vives-Bauza C, Vila MR, Shanske S, Hirano M et al (2003) Lack of paternal inheritance of muscle mitochondrial DNA in sporadic mitochondrial myopathies. Ann Neurol 54:524–526
Fukuhara N, Tokiguchi S, Shirakawa K, Tsubaki T (1980) Myoclonus epilepsy associated with ragged-red fibers (mitochondrial abnormalities): disease entity or a syndrome? J Neurol Sci 47:117–133
Gempel K, Topaloglu H, Talim B, Schneiderat P, Schoser BGH, Hans VH et al (2007) The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain 130:2037–2044
Ghezzi D, Goffrini P, Uziel G, Horvath R, Klopstock T, Lochmuller H et al (2009) SDHAF1, encoding a LYR complex II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy. Nat Genet 41:654–656
Gironi M, Lamperti C, Nemni R, Moggio M, Comi GP, Guerini FR et al (2004) Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency. Neurology 62:818–820
Gonatas NK, Shy GM (1965) Childhood myopathies with abnormal mitochondria. Proceedings of the Vth International Congress of Neuropathology Vol 100. Excerpta Medica International Congress Series, Amsterdam, pp 606–612
Goto Y, Nonaka I, Horai S (1990) A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348:651–653
Greaves LC, Preston SL, Tadrous PJ, Taylor RW, Barron MJ, Oukrif D, Leedham SJ et al (2006) Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by cryptic fission. Proc Natl Acad Sci USA 103:714–719
Guan M-X, Yan Q, Li X, Bykhovskaya Y, Gallo-Teran J, Hajek P et al (2006) Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12 S ribosomal RNA mutations. Am J Hum Genet 79:291302
Hakonen AH, Heiskanen S, Juvonen V, Lappalainen I, Luoma P, Rantamaki M et al (2005) Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 77:430–441
Hansen JJ, Durr A, Cournu-Rebeix I, Georgopoulos C, Ang D, Nyholm Nielsen M et al (2002) Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am J Hum Genet 70(5):1328–1332
Haut S, Brivet M, Tonati G, Rustin P, Lebon S, Garcia-Cazorla A et al (2003) A deletion in the human QP-C gene causes a complex III deficiency resulting in hypoglycaemia and lactic acidosis. Hum Genet 113:118–122
Haydar NA, Conn HL, Afifi A, Wakid N, Ballas S, Fawaz K (1971) Severe hypermetabolism with primary abnormality of skeletal muscle mitochondria. Ann Int Med 74:548–558
Hers HG (1965) Inborn lysosomal diseases. Gastroenterol 48:625–633
Hinson JT, Fantin VR, Schonberger J, Breivik N, Siem G, McDonough B et al (2007) Missense mutations in the BCS1L gene as a cause of the Bjornstad syndrome. New Engl J Med 356:809–819
Hirano M, Silvestri G, Blake D, Lombes A, Minetti C, Bonilla E et al (1994) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44:721–727
Hirano M, Garcia-de-Yebenes J, Jones AC, Nishino I, DiMauro S, Carlo JR et al (1998) Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE) syndrome maps to chromosome 22q13.32-qter. Am J Hum Genet 63:526–533
Hirano M, Marti R, Casali C, Tadesse BS, Uldrick T, Fine B et al (2006) Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 67:1458–1460
Holt IJ, Harding AE, Morgan Hughes JA (1988) Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331:717–719
Holt IJ, Harding AE, Petty RK, Morgan Hughes JA (1990) A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 46:428–433
Horvath R, Hudson G, Ferrari G, Futterer N, Ahola S, Lamantea E et al (2006) Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 129:1674–1684
Horvath R, Kemp JP, Tuppen HAL, Hudson G, Oldfors A, Marie SKN et al (2009) Molecular basis of infantile reversible cytochrome c oxidase deficiency. Brain 132:3165–3174
Hudson G, Keers S, Man PYW, Griffiths P, Huoponen K, Savontaus M-L et al (2005) Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder. Am J Hum Genet 77:1086–1091
Hudson G, Carelli V, Spruijt L, Gerards M, Mowbray C, Achilli A et al (2007) Clinical expression of leber hereditary optic neuropahy is affected by the mitochondrial DNA-haplogroup background. Am J Hum Genet 81:228–233
Hudson G, Amati-Bonneau P, Blakely E, Stewart JD, He L, Schaefer AM et al (2008) Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 131:329–337
Jacobs HT, Turnbull DM (2005) Nuclear genes and mitochondrial translation: a new class of genetic disease. Trends Genet 21:312–314
Jenuth JP, Peterson AC, Fu K, Shoubridge EA (1996) Random genetic drift in the female germline explains the rapid segregation of mammalian mitochondrial DNA. Nat Genet 14:146–151
Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Suzuki Y et al (1994) A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. New Engl J Med 330:962–968
Karadimas CL, Vu TH, Holve SA, Quinzii C, Tanji K, Bonilla E et al (2006) Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet 79:544–548
Karpati G, Carpenter S, Engel AG (1975) The syndrome of systemic carnitine deficiency. Neurology 25:16–24
Kaufmann P, Shungu D, Sano MC, Jhung S, Engelstad K, Mitsis E et al (2004) Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 62:1297–1302
Kaukonen J, Juselius JK, Tiranti V, Kyttala A, Zeviani M, Comi GP et al (2000) Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289:782–785
King MP, Attardi G (1989) Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246:500–503
King MP, Koga Y, Davidson M, Schon EA (1992) Defects in mitochondrial protein synthesis and respiratory chain activity segragate with the tRNALeu(UUR) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Mol Cell Biol 12:480–490
Kirby DM, Salemi R, Sugiana C, Ohtake A, Parry L, Bell KM et al (2004) NUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency. J Clin Invest 114:837–845
Kraytsberg Y, Schwartz M, Brown TA, Ebralidse K, Kunz WS, Clayton DA et al (2004) Recombination of human mitochondrial DNA. Science 304:981
Lagier-Tourenne C, Tazir M, Lopez LC, Quinzii C, Assoum M, Drouot N et al (2008) ADSK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am J Hum Genet 82:661–672
Lalani S, Vladutiu GD, Plunkett K, Lotze TE, Adesina AM, Scaglia F (2005) Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency. Arch Neurol 62:317–320
Lamperti C, Naini A, Hirano M, De Vivo DC, Bertini E, Servidei S et al (2003) Cerebellar ataxia and coenzyme Q10 deficiency. Neurology 60:1206–1208
Ledley FD, Jansen R, Nham SU, Fenton WA, Rosenberg LE (1990) Mutation eliminating mitochondrial leader sequence of methylmalonyl-CoA mutase causes mut0 methylmalonic acidemia. Proc Natl Acad Sci USA 87:3147–3150
Lestienne P, Ponsot G (1988) Kearns-Sayre syndrome with muscle mitochondrial DNA deletion. Lancet 1:885
Lopez LC, Quinzii C, Schuelke M, Kanki T, Naini A, DiMauro S et al (2006) Leigh syndrome with nephropathy and CoQ10 deficiency due to decaproneyl diphosphate synthase subunit 2 (PDSS2) mutations. Am J Hum Genet 79:1125–1129
Luft R, Ikkos D, Palmieri G, Ernster L, Afzelius B (1962) A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest 41:1776–1804
Magen D, Georgopoulos C, Bross P, Ang D, Segev Y, Goldsher D et al (2008) Mitochondrial Hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am J Hum Genet 83:30–42
Mangiullo R, Gnoni A, Leone A, Gnoni GV, Papa S, Zanotti F (2008) Structural and functional characterization of F0F1-ATP synthase on the extracellular surface of rat hepatocytes. Biochim Biophys Acta 1777:1326–1335
Manwaring N, Jones MM, Wang JJ, Rochtchina E, Howard C, Mitchell P et al (2007) Population prevalence of the MELAS A3243G mutation. Mitochondrion 7:230–233
Marti R, Nishigaki Y, Hirano M (2003) Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency. Biochem Biophys Res Comm 303:14–18
Massa V, Fernandez-Vizarra E, Alshahwan S, Bakhsh E, Goffrini P, Ferrero I et al (2008) Severe infantile encephalomyopathy caused by a mutation in COX6B1, a nucleus-encoded subunit of cytochrome c oxidase. Am J Hum Genet. doi:10.1016/j.ajhg.2008.05.002
Masucci JP, Davidson M, Koga Y, Schon EA, King MP (1995) In vitro analysis of mutations causing myoclonus epilepsy with ragged-red fibers in the mitochondrial tRNALys gene: two genotypes produce similar phenotypes. Mol Cell Biol 15:2872–2881
McKenzie M, Lazarou M, Thorburn DR, Ryan MT (2006) Mitochondrial respiratory chain supercomplexes are destabilized in Barth syndrome patients. J Mol Biol 361:462–469
Miller C, Saada A, Shaul N, Shabtai N, Ben-Shalom E, Shaag E et al (2004) Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation. Ann Neurol 56:734–738
Mollet J, Giurgea I, Schlemmer D, Dallner G, Chretien D, Delahodde A et al (2007) Prenyldiphosphate synthase (PDSS1) and OH-benzoate prenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J Clin Invest 117:765–772
Mollet J, Delahodde A, Serre V, Chretien D, Schlemmer D, Lombes A et al (2008) CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet 82:623–630
Mootha VK, Lepage P, Miller K, Bunkenborg J, Reich M, Hjerrild M et al (2003) Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci USA 100:605–610
Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF et al (1989) Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome `see comments. N Engl J Med 320:1293–1299
Moraes CT, Shanske S, Tritschler HJ, Aprille JR, Andreetta F, Bonilla E et al (1991) MtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 48:492–501
Moraes CT, Ricci E, Bonilla E, DiMauro S, Schon EA (1992) The mitochondrial tRNALeu(UUR) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle. Am J Hum Genet 50:934–949
Morais R, Desjardins P, Turmel C, Zinkewich-Peotti K (1988) Development and characterization of continuous avian cell lines depleted of mitochondrial DNA. In Vitro Cell Dev Biol 24:649–658
Musumeci O, Naini A, Slonim AE, Scavin N, Hadjigeorgiou GL, Krawiecki N et al (2001) Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 56:849–855
Nass MMK, Nass S (1963a) fibers with DNA characteristics. I. Fixation and electron staining reactions. J Cell Biol 19:593–612
Nass S, Nass M (1963b) Intramitochondrial fibers with DNA characteristics. II. Enzymatic and other hydrolytic treatments. J Cell Biol 19:613–629
Naviaux RK, Nguyen KV (2004) POLG mutations associated with Alpers′ syndrome and mitochondrial DNA depletion. Ann Neurol 55:706–712
Naviaux RK, Nyhan WL, Barshop BA, Poulton J, Markusic D, Karpinski NC et al (1999) Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers′ syndrome. Ann Neurol 45:54–58
Nishigaki Y, Marti RA, Copeland WC, Hirano M (2003) Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J Clin Invest 111:1913–1921
Nishino I, Spinazzola A, Hirano M (1999) Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283:689–692
Ogasahara S, Engel AG, Frens D, Mack D (1989) Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 86:2379–2382
Ogilvie I, Kennaway NG, Shoubridge EA (2005) A molecular chaperone for mitochondrial complex I assembly is mutated in a progressive encephalopathy. J Clin Invest 115:2784–2792
Papadopoulou LC, Sue CM, Davidson MM, Tanji K, Nishino I, Sadlock JE et al (1999) Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 23:333–337
Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP (1984) Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 16:481–488
Petty RK, Harding AE, Morgan Hughes JA (1986) The clinical features of mitochondrial myopathy. Brain 109:915–938
Poulton J, Hirano M, Spinazzola A, Arenas Hernandez M, Jardel C, Lombes A et al (2009) Collated mutations in mitochondrial DNA (mtDNA) depletion syndrome (excludingbthe mitochondrial gamma polymerase, POLG1). Biochim Biophys Acta 1792:1109–1112
Prezant TR, Agapian JV, Bohlman MC, Bu X, Oztas S, Qiu W-Q et al (1993) Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 4:289–293
Quinzii C, Kattah AG, Naini A, Akman HO, Mootha VK, DiMauro S et al (2005) Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 64:539–541
Quinzii C, Naini A, Salviati L, Trevisson E, Navas P, DiMauro S et al (2006) A mutation in para-Hydoxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet 78:345–349
Ravera S, Panfoli I, Calzia D, Aluigi MG, Bianchini P, Diaspro A et al (2009) Evidence for aerobic ATP synthesis in isolated myelin vesicles. Int J Biochem Cell Biol 41:1581–1591
Roesch K, Curran SP, Tranebjaerg L, Koehler CM (2002) Human deafness dystonia syndrome is caused by a defect in assembly of the DDP1/TIMM8a-TIMM13 complex. Hum Mol Genet 11:477–486
Rotig A, Appelkvist E-L, Geromel V, Chretien D, Kadhom N, Edery P et al (2000) Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 356:391–395
Rotig A, Poulton J (2009) Genetic causes of mitochondrial DNA depletion in humans. Biochim Biophys Acta 1792:1103–1108
Rowland LP (1994) Mitochondrial encephalomyopathies: lumping, splitting, and melding. In: Schapira AHV, DiMauro S (eds) Mitochondrial disorders in neurology. Butterworth-Heinemann, Oxford, pp 116–129
Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O (2001) Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 29:342–344
Sacconi S, Salviati L, Nishigaki Y, Walker WF, Hernandez-Rosa E, Trevisson E et al (2008) A functionally dominant mitochondrial DNA mutation. Hum Mol Genet 17:1814–1820
Salviati L, Sacconi S, Murer L, Zacchello G, Franceschini L, Laverda AM et al (2005) Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition. Neurology 65:606–608
Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF (2004) The epidemiology of mitochondrial disorders-past, present and future. Biochim Biophys Acta 1659:115–120
Schaefer AM, McFarland R, Blakely E, Langping H, Whittaker RG, Taylor RW et al (2008) Prevalence of mitochondrial DNA disease in adults. Ann Neurol 63(1):35–39
Scheffler IE (1986) Biochemical genetics of respiration-deficient mutants of animal cells. In: Morgan MJ (ed) Carbohydrate metabolism in cultured cells. Plenum, London, pp 77–109
Scheper GC, Klok VD, van Andel RJ, van Berkel CGM, Sissler M, Smet J et al (2007) Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 39:534–538
Schlame M, Ren M (2006) Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett 580:5450–5455
Schlame M, Towbin JA, Heerdt PM, Jehle R, DiMauro S, Blanck TJJ (2002) Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann Neurol 51:634–637
Schwartz F, Vissing J (2004) No evidence of paternal inheritance of mtDNA in patients with sporadic mtDNA mutations. J Neurol Sci 218:99–101
Schwartz M, Vissing J (2002) Paternal inheritance of mitohondrial DNA. New Engl J Med 347:576–580
Servidei S (2001) Mitochondrial encephalomyopathies: gene mutation. Neuromuscul Disord 14:107–116
Shankar SP, Fingert JH, Carelli V, Valentino ML, King TM, Daiger SP et al (2008) Evidence for a novel X-linked modifier locus for Leber hereditary optic neuropathy. Opthal Genet 29:17–24
Shapira Y, Harel S, Russell A (1977) Mitochondrial encephalomyopathies: a group of neuromuscular disorders with defects in oxidative metabolism. Isr J Med Sci 13:161–164
Shoffner JM, Lott MT, Lezza A, Seibel P, Ballinger SW, Wallace DC (1990) Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell 61:931–937
Shy GM, Gonatas NK (1964) Human myopathy with giant abnormal mitochondria. Science 145:493–496
Shy GM, Gonatas NK (1966) Two childhood myopathies with abnormal mitochondria: I. Megaconial myopathy; II. Pleoconial myopathy. Brain 89:133–158
Skladal D, Halliday J, Thorburn DR (2003) Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126:1905–1912
Smeitink J, van den Heuvel L (1999) Protein biosynthesis ′99: human mitochondrial complex I in health and disease. Am J Hum Genet 64:1505–1510
Smeitink JAM, Elpeleg O, Antonicka H, Diepstra H, Saada A, Smits P et al (2006) Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs. Am J Hum Genet 79:869–877
Sobreira C, Hirano M, Shanske S, Keller RK, Haller RG, Davidson E et al (1997) Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology 48:1238–1243
Spelbrink JN, Li FY, Tiranti V, Nikali K, Yuan QP, Tariq M et al (2001) Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 28:200–201
Sperl W, Jesina P, Zeman J, Mayr JA, DeMeirleir L, VanCoster R et al (2006) Deficiency of mitochondrial ATP synthase of nuclear origin. Neuromuscul Disord 16:821–829
Spinazzola A, Marti R, Nishino I, Andreu AL, Naini A, Tadesse S et al (2002) Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 277:4128–4132
Spinazzola A, Zeviani M (2005) Disorders of nuclear-mitochondrial intergenomic signaling. Gene 354:162–168
Spinazzola A, Invernizzi F, Carrara F, Lamantea E, Donati A, Dirocco M, Giordano I et al (2009) Clinical and molecular features of mitochondrial DNA depletion syndromes. J Inherit Metab Dis 32:143–158
Spiro AJ, Moore CL, Prineas JW, Strasberg PM, Rapin I (1970) A cytochrome-related inherited disorder of the nervous system and muscle. Arch Neurol 23:103–112
Sue CM, Tanji K, Hadjigeorgiou G, Andreu AL, Nishino I, Krishna S et al (1999) Maternally inherited hearing loss in a large kindred with a novel mutation in the mitochondrial DNA tRNASer(UCN) gene. Neurology 52:1905–1908
Takakubo F, Cartwright P, Hoogenraad N, Thorburn DR, Collins F, Lithgow T et al (1995) An amino acid substitution in the pyruvate dehydrogenase E1a gene, affecting mitochondrial import of the precursor protein. Am J Hum Genet 57:772–780
Tanji K, Bonilla E (2001) Optical imaging techniques (histochemical, immunohistochemical, and in situ hybridization staining methods) to visualize mitochondria. Meth Cell Biol 65:311–332
Tatuch Y, Christodoulou J, Feigenbaum A, Clarke J, Wherret J, Smith C et al (1992) Heteroplasmic mtDNA mutation (T > G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 50:852–858
Taylor RW, Giordano C, Davidson MM, d’Amati G, Bain H, Hayes CM et al (2003a) A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited cardiomyopathy. J Am Coll Cardiol 41:1786–1796
Taylor RW, McDonnell MT, Blakely EL, Chinnery PF, Taylor GA, Howell N et al (2003b) Genotypes from patients indicate no paternal mitochondrial contribution. Ann Neurol 54:521–524
Tiranti V, Hoertnagel K, Carrozzo R, Galimberti C, Munaro M, Granatiero M et al (1998) Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 63:1609–1621
Tiranti V, D'Adamo P, Briem E, Ferrari G, Mineri R, Lamantea E et al (2004) Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet 74:239–252
Tiranti V, Briem E, Lamantea E, Mineri R, Papaleo E, De Gioia L et al (2006) ETHE1 mutations are specific to ethylmalonic encephalopathy. J Med Genet 43:340–346
Tiranti V, Visconti C, Hildebrandt T, Di Meo I, Mineri R, Tiveron C et al (2009) Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med 15:200–205
Tzoulis C, Engelsen BA, Telstad W, Aasly J, Zeviani M, Winterthun S et al (2006) The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 129:1685–1692
Valente L, Tiranti V, Marsano RM, Malfatti E, Fernandez-Vizarra E, Donnini C et al (2007) Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EGF1 and EFTu. Am J Hum Genet 80:44–58
Valnot I, Osmond S, Gigarel N, Mehaye B, Amiel J, Cormier-Daire V et al (2000a) Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet 67:1104–1109
Valnot I, von Kleist-Retzow J-C, Barrientos A, Gorbatyuk M, Taanman J-W, Mehaye B et al (2000b) A mutation in the human heme-A:farnesyltransferase gene (COX 10) causes cytochrome c oxidase deficiency. Hum Mol Genet 9:1245–1249
Van Goethem G, Dermaut B, Lofgren A, Martin J-J, Van Broeckhoven C (2001) Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 28:211–212
Van Maldergem L, Trijbels F, DiMauro S, Sindelar PJ, Musumeci O, Janssen A et al (2002) Coenzyme Q-responsive Leigh's encephalopathy in two sisters. Ann Neurol 52:750–754
Visapaa I, FEellman V, Vesa J, Dasvarma A, Hutton JL, Kumar V et al (2002) GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet 71:863–876
Vreken P, Valianpour F, Nijtmans LG, Grivell LA, Plecko B, Wanders RJ et al (2000) Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys Res Comm 279:378–382
Wai T, Teoli D, Shoubridge EA (2010) The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes. Nat Genet 40:1484–1488
Wallace DC (2005) The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement. Gene 354:169–180
Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza A et al (1988) Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242:1427–1430
Willems JL, Monnens L, Trijbels J, Veerkamp JH, Meyer A, van Dam K et al (1977) Leigh's encephalomyelopathy in a patient with cytochrome c oxidase deficiency in muscle tissue. Pediatrics 60:850–857
Yu Y, Malhotra A, Ren M, Schlame M (2006) The enzymatic function of tafazzin. J Biol Chem 281:39217–39224
Zanna C, Ghelli A, Porcelli AM, Karbowski M, Youle RJ, Schimpf S et al (2008) OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 131:352–367
Zeviani M, Moraes CT, DiMauro S (1988) Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 38:1339–1346
Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S, DiDonato S (1989) An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 339:309–311
Zhu Z, Yao J, Johns T, Fu K, De Bie I, Macmillan C et al (1998) SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 20:337–343
Zuchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL et al (2004) Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 36:449–451
Acknowledgements
I thank my colleagues and friends Eric Schon and Michio Hirano for reviewing the manuscript.
This work was supported by NIH grant HD032062 and by the Marriott Mitochondrial Clinical Research Fund (MMCRF).
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Jan Smeitink
Competing interests:
None declared.
Rights and permissions
About this article
Cite this article
DiMauro, S. A history of mitochondrial diseases. J Inherit Metab Dis 34, 261–276 (2011). https://doi.org/10.1007/s10545-010-9082-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-010-9082-x